Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030
Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource...
Ausführliche Beschreibung
Autor*in: |
Sarria, Gustavo R [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2022 |
---|
Übergeordnetes Werk: |
Enthalten in: My - Citovsky, Vitaly ELSEVIER, 2019, London |
---|---|
Übergeordnetes Werk: |
volume:23 ; year:2022 ; pages:5 |
Links: |
---|
DOI / URN: |
10.1016/S1470-2045(22)00404-1 |
---|
Katalog-ID: |
ELV058359338 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV058359338 | ||
003 | DE-627 | ||
005 | 20230625005139.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220808s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/S1470-2045(22)00404-1 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001882.pica |
035 | |a (DE-627)ELV058359338 | ||
035 | |a (ELSEVIER)S1470-2045(22)00404-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 570 |q VZ |
084 | |a BIODIV |q DE-30 |2 fid | ||
084 | |a 35.70 |2 bkl | ||
084 | |a 42.12 |2 bkl | ||
100 | 1 | |a Sarria, Gustavo R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 |
264 | 1 | |c 2022 | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030. | ||
700 | 1 | |a Martinez, David A |4 oth | |
700 | 1 | |a Del Castillo, Ruben |4 oth | |
700 | 1 | |a Salgado, Apolo |4 oth | |
700 | 1 | |a Pinillos, Luis |4 oth | |
700 | 1 | |a Felix, Armando |4 oth | |
700 | 1 | |a Bobadilla, Ivan |4 oth | |
700 | 1 | |a Ferraris, Gustavo |4 oth | |
700 | 1 | |a Polo, Alfredo |4 oth | |
700 | 1 | |a Sarria, Gustavo J |4 oth | |
773 | 0 | 8 | |i Enthalten in |n The Lancet Publ. Group |a Citovsky, Vitaly ELSEVIER |t My |d 2019 |g London |w (DE-627)ELV003173852 |
773 | 1 | 8 | |g volume:23 |g year:2022 |g pages:5 |
856 | 4 | 0 | |u https://doi.org/10.1016/S1470-2045(22)00404-1 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-BIODIV | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 35.70 |j Biochemie: Allgemeines |q VZ |
936 | b | k | |a 42.12 |j Biophysik |q VZ |
951 | |a AR | ||
952 | |d 23 |j 2022 |h 5 |y 23.2022, S5- |
author_variant |
g r s gr grs |
---|---|
matchkey_str |
sarriagustavormartinezdavidadelcastillor:2022----:aiteayncnesauiltnmrceooiaayioivsm |
hierarchy_sort_str |
2022 |
bklnumber |
35.70 42.12 |
publishDate |
2022 |
allfields |
10.1016/S1470-2045(22)00404-1 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001882.pica (DE-627)ELV058359338 (ELSEVIER)S1470-2045(22)00404-1 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Sarria, Gustavo R verfasserin aut Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030. Martinez, David A oth Del Castillo, Ruben oth Salgado, Apolo oth Pinillos, Luis oth Felix, Armando oth Bobadilla, Ivan oth Ferraris, Gustavo oth Polo, Alfredo oth Sarria, Gustavo J oth Enthalten in The Lancet Publ. Group Citovsky, Vitaly ELSEVIER My 2019 London (DE-627)ELV003173852 volume:23 year:2022 pages:5 https://doi.org/10.1016/S1470-2045(22)00404-1 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 23 2022 5 23.2022, S5- |
spelling |
10.1016/S1470-2045(22)00404-1 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001882.pica (DE-627)ELV058359338 (ELSEVIER)S1470-2045(22)00404-1 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Sarria, Gustavo R verfasserin aut Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030. Martinez, David A oth Del Castillo, Ruben oth Salgado, Apolo oth Pinillos, Luis oth Felix, Armando oth Bobadilla, Ivan oth Ferraris, Gustavo oth Polo, Alfredo oth Sarria, Gustavo J oth Enthalten in The Lancet Publ. Group Citovsky, Vitaly ELSEVIER My 2019 London (DE-627)ELV003173852 volume:23 year:2022 pages:5 https://doi.org/10.1016/S1470-2045(22)00404-1 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 23 2022 5 23.2022, S5- |
allfields_unstemmed |
10.1016/S1470-2045(22)00404-1 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001882.pica (DE-627)ELV058359338 (ELSEVIER)S1470-2045(22)00404-1 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Sarria, Gustavo R verfasserin aut Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030. Martinez, David A oth Del Castillo, Ruben oth Salgado, Apolo oth Pinillos, Luis oth Felix, Armando oth Bobadilla, Ivan oth Ferraris, Gustavo oth Polo, Alfredo oth Sarria, Gustavo J oth Enthalten in The Lancet Publ. Group Citovsky, Vitaly ELSEVIER My 2019 London (DE-627)ELV003173852 volume:23 year:2022 pages:5 https://doi.org/10.1016/S1470-2045(22)00404-1 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 23 2022 5 23.2022, S5- |
allfieldsGer |
10.1016/S1470-2045(22)00404-1 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001882.pica (DE-627)ELV058359338 (ELSEVIER)S1470-2045(22)00404-1 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Sarria, Gustavo R verfasserin aut Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030. Martinez, David A oth Del Castillo, Ruben oth Salgado, Apolo oth Pinillos, Luis oth Felix, Armando oth Bobadilla, Ivan oth Ferraris, Gustavo oth Polo, Alfredo oth Sarria, Gustavo J oth Enthalten in The Lancet Publ. Group Citovsky, Vitaly ELSEVIER My 2019 London (DE-627)ELV003173852 volume:23 year:2022 pages:5 https://doi.org/10.1016/S1470-2045(22)00404-1 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 23 2022 5 23.2022, S5- |
allfieldsSound |
10.1016/S1470-2045(22)00404-1 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001882.pica (DE-627)ELV058359338 (ELSEVIER)S1470-2045(22)00404-1 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Sarria, Gustavo R verfasserin aut Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030. Martinez, David A oth Del Castillo, Ruben oth Salgado, Apolo oth Pinillos, Luis oth Felix, Armando oth Bobadilla, Ivan oth Ferraris, Gustavo oth Polo, Alfredo oth Sarria, Gustavo J oth Enthalten in The Lancet Publ. Group Citovsky, Vitaly ELSEVIER My 2019 London (DE-627)ELV003173852 volume:23 year:2022 pages:5 https://doi.org/10.1016/S1470-2045(22)00404-1 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 23 2022 5 23.2022, S5- |
language |
English |
source |
Enthalten in My London volume:23 year:2022 pages:5 |
sourceStr |
Enthalten in My London volume:23 year:2022 pages:5 |
format_phy_str_mv |
Article |
bklname |
Biochemie: Allgemeines Biophysik |
institution |
findex.gbv.de |
dewey-raw |
570 |
isfreeaccess_bool |
false |
container_title |
My |
authorswithroles_txt_mv |
Sarria, Gustavo R @@aut@@ Martinez, David A @@oth@@ Del Castillo, Ruben @@oth@@ Salgado, Apolo @@oth@@ Pinillos, Luis @@oth@@ Felix, Armando @@oth@@ Bobadilla, Ivan @@oth@@ Ferraris, Gustavo @@oth@@ Polo, Alfredo @@oth@@ Sarria, Gustavo J @@oth@@ |
publishDateDaySort_date |
2022-01-01T00:00:00Z |
hierarchy_top_id |
ELV003173852 |
dewey-sort |
3570 |
id |
ELV058359338 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV058359338</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625005139.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1470-2045(22)00404-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001882.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV058359338</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1470-2045(22)00404-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sarria, Gustavo R</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martinez, David A</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Del Castillo, Ruben</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salgado, Apolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pinillos, Luis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Felix, Armando</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bobadilla, Ivan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferraris, Gustavo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Polo, Alfredo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sarria, Gustavo J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">The Lancet Publ. Group</subfield><subfield code="a">Citovsky, Vitaly ELSEVIER</subfield><subfield code="t">My</subfield><subfield code="d">2019</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV003173852</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1470-2045(22)00404-1</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2022</subfield><subfield code="h">5</subfield><subfield code="y">23.2022, S5-</subfield></datafield></record></collection>
|
author |
Sarria, Gustavo R |
spellingShingle |
Sarria, Gustavo R ddc 570 fid BIODIV bkl 35.70 bkl 42.12 Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 |
authorStr |
Sarria, Gustavo R |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV003173852 |
format |
electronic Article |
dewey-ones |
570 - Life sciences; biology |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 |
topic |
ddc 570 fid BIODIV bkl 35.70 bkl 42.12 |
topic_unstemmed |
ddc 570 fid BIODIV bkl 35.70 bkl 42.12 |
topic_browse |
ddc 570 fid BIODIV bkl 35.70 bkl 42.12 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
d a m da dam c r d cr crd a s as l p lp a f af i b ib g f gf a p ap g j s gj gjs |
hierarchy_parent_title |
My |
hierarchy_parent_id |
ELV003173852 |
dewey-tens |
570 - Life sciences; biology |
hierarchy_top_title |
My |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV003173852 |
title |
Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 |
ctrlnum |
(DE-627)ELV058359338 (ELSEVIER)S1470-2045(22)00404-1 |
title_full |
Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 |
author_sort |
Sarria, Gustavo R |
journal |
My |
journalStr |
My |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science |
recordtype |
marc |
publishDateSort |
2022 |
contenttype_str_mv |
zzz |
container_start_page |
5 |
author_browse |
Sarria, Gustavo R |
container_volume |
23 |
class |
570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Sarria, Gustavo R |
doi_str_mv |
10.1016/S1470-2045(22)00404-1 |
dewey-full |
570 |
title_sort |
radiotherapy and cancer status in latin america: economic analysis of investment opportunities up to 2030 |
title_auth |
Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 |
abstract |
Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030. |
abstractGer |
Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030. |
abstract_unstemmed |
Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
title_short |
Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030 |
url |
https://doi.org/10.1016/S1470-2045(22)00404-1 |
remote_bool |
true |
author2 |
Martinez, David A Del Castillo, Ruben Salgado, Apolo Pinillos, Luis Felix, Armando Bobadilla, Ivan Ferraris, Gustavo Polo, Alfredo Sarria, Gustavo J |
author2Str |
Martinez, David A Del Castillo, Ruben Salgado, Apolo Pinillos, Luis Felix, Armando Bobadilla, Ivan Ferraris, Gustavo Polo, Alfredo Sarria, Gustavo J |
ppnlink |
ELV003173852 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth |
doi_str |
10.1016/S1470-2045(22)00404-1 |
up_date |
2024-07-06T18:47:30.456Z |
_version_ |
1803856537669599232 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV058359338</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625005139.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1470-2045(22)00404-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001882.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV058359338</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1470-2045(22)00404-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sarria, Gustavo R</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martinez, David A</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Del Castillo, Ruben</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salgado, Apolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pinillos, Luis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Felix, Armando</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bobadilla, Ivan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferraris, Gustavo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Polo, Alfredo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sarria, Gustavo J</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">The Lancet Publ. Group</subfield><subfield code="a">Citovsky, Vitaly ELSEVIER</subfield><subfield code="t">My</subfield><subfield code="d">2019</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV003173852</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1470-2045(22)00404-1</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2022</subfield><subfield code="h">5</subfield><subfield code="y">23.2022, S5-</subfield></datafield></record></collection>
|
score |
7.4030714 |